Dawn E Sugarman1,2, Lisa E Horvitz1, Shelly F Greenfield1,2, Alisa B Busch1,2,3. 1. McLean Hospital, Belmont, Massachusetts, USA. 2. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA. 3. Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA.
Abstract
Background: Little is known about specialty mental health and/or substance use disorder (MH/SUD) clinicians' experiences transitioning from in-person to telehealth care, to treat a diagnostically diverse population during the COVID-19 pandemic. Methods: Survey of outpatient MH/SUD clinicians (psychiatrists, nurse practitioners, psychologists, and licensed clinical social workers; N = 107) at a psychiatric hospital. Clinician satisfaction and experiences using telehealth across a variety of services (individual, group or family therapy, initial assessments, evaluation and management, and neuropsychological assessment) were assessed using a mixed-methods approach. Results: Across services, a majority agreed/strongly agreed that telehealth provided an opportunity to build rapport with patients (67-88%) and they could treat their patients' needs well (71-88%). The interest in continuing to use telehealth when in-person visits resume varied by type of service provided (50-71%). Group therapy and initial assessment were lowest (50% and 51%, respectively). Clinicians noted telehealth improved access to care for patients with logistical barriers, competing demands, mobility difficulties, and medical concerns; but was more challenging to care for patients with certain psychiatric characteristics (e.g., psychosis, paranoia, catatonia, high distractibility, and avoidance), high symptom severity, or who needed to improve social skills. Telehealth influenced the therapeutic process (e.g., observations of family dynamic, increased patient/clinician therapeutic alliance). Discussion and Conclusions: MH/SUD clinicians who quickly transitioned to telehealth care during the pandemic were largely satisfied with telehealth, but also identified challenges related to specific patient characteristics, or types of MH/SUD services. These observations warrant additional study to better delineate the role for an expanded use of telehealth postpandemic.
Background: Little is known about specialty mental health and/or substance use disorder (MH/SUD) clinicians' experiences transitioning from in-person to telehealth care, to treat a diagnostically diverse population during the COVID-19 pandemic. Methods: Survey of outpatient MH/SUD clinicians (psychiatrists, nurse practitioners, psychologists, and licensed clinical social workers; N = 107) at a psychiatric hospital. Clinician satisfaction and experiences using telehealth across a variety of services (individual, group or family therapy, initial assessments, evaluation and management, and neuropsychological assessment) were assessed using a mixed-methods approach. Results: Across services, a majority agreed/strongly agreed that telehealth provided an opportunity to build rapport with patients (67-88%) and they could treat their patients' needs well (71-88%). The interest in continuing to use telehealth when in-person visits resume varied by type of service provided (50-71%). Group therapy and initial assessment were lowest (50% and 51%, respectively). Clinicians noted telehealth improved access to care for patients with logistical barriers, competing demands, mobility difficulties, and medical concerns; but was more challenging to care for patients with certain psychiatric characteristics (e.g., psychosis, paranoia, catatonia, high distractibility, and avoidance), high symptom severity, or who needed to improve social skills. Telehealth influenced the therapeutic process (e.g., observations of family dynamic, increased patient/clinician therapeutic alliance). Discussion and Conclusions: MH/SUD clinicians who quickly transitioned to telehealth care during the pandemic were largely satisfied with telehealth, but also identified challenges related to specific patient characteristics, or types of MH/SUD services. These observations warrant additional study to better delineate the role for an expanded use of telehealth postpandemic.
Authors: Ateev Mehrotra; Anupam B Jena; Alisa B Busch; Jeffrey Souza; Lori Uscher-Pines; Bruce E Landon Journal: JAMA Date: 2016-05-10 Impact factor: 56.272
Authors: Alessandro Cuomo; Mario Amore; Maria Felice Arezzo; Sergio De Filippis; Alessandra De Rose; Silvestro La Pia; Alessandro Pirani; Riccardo Torta; Andrea Fagiolini Journal: Ann Gen Psychiatry Date: 2022-08-10 Impact factor: 3.301
Authors: Rosemarie Martin; Augustine W Kang; Audrey A DeBritz; Mary R Walton; Ariel Hoadley; Courtney DelaCuesta; Linda Hurley Journal: Int J Environ Res Public Health Date: 2021-06-07 Impact factor: 3.390
Authors: Ekaterina Anderson; Kelly Dvorin; Bella Etingen; Anna M Barker; Zenith Rai; Abigail Herbst; Reagan Mozer; Rodger P Kingston; Barbara Bokhour Journal: Glob Adv Health Med Date: 2022-01-25